Publications by authors named "Erica Dorillo"

Claim this Profile
B
Bcor loss promotes Richter transformation of chronic lymphocytic leukemia associated with Notch1 activation in mice.
Chiara Rompietti, Francesco Maria Adamo, Daniele Sorcini, Filomena De Falco, Arianna Stella, Erica Dorillo

Leukemia· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanotechnology Advances in the Detection and Treatment of Lymphoid Malignancies.
Francesco Maria Adamo, Filomena De Falco, Erica Dorillo, Daniele Sorcini, Arianna Stella

Int J Mol Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
-
-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential.
Estevão Carlos Silva Barcelos, Chiara Rompietti, Francesco Maria Adamo, Erica Dorillo, Filomena De Falco

Front Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia.
Francesco Maria Adamo, Estevao Carlos Silva Barcelos, Filomena De Falco, Erica Dorillo, Chiara Rompietti

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia.
Daniele Sorcini, Filomena De Falco, Marco Gargaro, Silvia Bozza, Valerio Guarente, Erica Dorillo

Br J Haematol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL.
Filomena De Falco, Chiara Rompietti, Daniele Sorcini, Angela Esposito, Annarita Scialdone, Erica Dorillo

Cell Death Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML.
Ilaria Gionfriddo, Lorenzo Brunetti, Federica Mezzasoma, Francesca Milano, Valeria Cardinali, Erica Dorillo

Leukemia· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia.
Valerio Guarente, Giovanni Martino, Erica Dorillo, Filomena De Falco, Chiara Rompietti

Front Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models.
Stefano Baldoni, Loredana Ruggeri, Beatrice Del Papa, Daniele Sorcini, Francesco Guardalupi, Erica Dorillo

Bone Marrow Transplant· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications.
Paolo Sportoletti, Filomena De Falco, Beatrice Del Papa, Stefano Baldoni, Valerio Guarente, Erica Dorillo

Int J Mol Sci· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the and Mutational Status.
Stefano Baldoni, Beatrice Del Papa, Filomena De Falco, Erica Dorillo, Carlo Sorrentino

Front Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia.
Beatrice Del Papa, Stefano Baldoni, Erica Dorillo, Filomena De Falco, Chiara Rompietti

Clin Cancer Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia.
Stefano Baldoni, Beatrice Del Papa, Erica Dorillo, Patrizia Aureli, Filomena De Falco

Int J Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia.
Emanuela Rosati, Stefano Baldoni, Filomena De Falco, Beatrice Del Papa, Erica Dorillo

Front Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells.
Mauro Di Ianni, Stefano Baldoni, Beatrice Del Papa, Patrizia Aureli, Erica Dorillo

Front Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome.
Elisa Albi, Stefano Baldoni, Patrizia Aureli, Erica Dorillo, Beatrice Del Papa

Tumori· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion.
Stefano Baldoni, Paolo Sportoletti, Beatrice Del Papa, Patrizia Aureli, Erica Dorillo

Int J Hematol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis